Xiaobo Liu

Cleveland Clinic

Papers

1

Total Citations

132

H-Index

1

About

Xiaobo Liu is a surgical researcher whose work sits at the intersection of minimally invasive gynecologic surgery and endometriosis management. Liu's most prominent contribution to the field is the landmark multicenter randomized controlled trial known as LAROSE (Laparoscopy vs. Robotic Surgery for Endometriosis), published in 2017, which has garnered 132 citations and represents one of the most rigorous head-to-head comparisons of two leading surgical approaches for treating endometriosis. By designing a controlled, multicenter framework, Liu helped address a critical gap in evidence-based gynecologic surgery at a time when robotic platforms were rapidly expanding into clinical practice without robust comparative data. The trial's findings have informed surgical decision-making for clinicians worldwide, contributing meaningfully to ongoing debates about the cost-effectiveness and clinical outcomes of robotic versus conventional laparoscopic techniques. Liu's research exemplifies the importance of high-quality randomized evidence in guiding the adoption of emerging surgical technologies, and the LAROSE trial continues to serve as an essential reference for gynecologic surgeons, researchers, and policymakers navigating the evolving landscape of endometriosis treatment.

Research Focus

Key Achievements

1
H-Index
1
Papers
132
Total Citations
132
Avg Citations/Paper
🏆 Most Cited Paper
Laparoscopy vs. Robotic Surgery for Endometriosis (LAROSE): a multicenter, randomized, controlled trial
132 citations · 2017
📈 Most Prolific Year: 2017 (1 Papers)
🤝 Key Collaborators: 7
🏛 Institutions: Cleveland Clinic

Top Papers

  1. 1

Key Collaborators

Contact & Links

Available for collaboration
Content generated · 14 days ago